Glenmark Pharmaceuticals Ltd NSE  /  BSE

Pharmaceuticals, Mid Cap

24 Nov 2020 | 04:14 PM

480.50
0.65 (0.14%)

  • Outperforms Index

    37.52%

    Return (1Y)

    Beaten Nifty 200 by 29%

  • More Volatile

    3.74%

    Standard Deviation (1Y)

    Higher than Nifty 200 by 1.85%

  • Not so consistent

    6/12

    Months

    underperformed Nifty 200

  • AxisDirect View

    No View

52 Week High-Low

573

573.05

162

161.65

News & Announcements

Price vs Volume

Stock Trivia

  • FII shareholding in Glenmark Pharmaceuticals Ltd has increased by 10.21% since past 3 Months

  • MF shareholding in Glenmark Pharmaceuticals Ltd has increased by 51.36% since past 3 Months

  • FII shareholding in Glenmark Pharmaceuticals Ltd has decreased by -17.79% since past 1 Year

  • MF shareholding in Glenmark Pharmaceuticals Ltd has decreased by -17.37% since past 1 Year

Loading...